Literature DB >> 27129761

Elective Total Knee Arthroplasty in Patients With End-Stage Renal Disease: Is It a Safe Procedure?

Alejandro Lizaur-Utrilla1, Daniel Martinez-Mendez2, Isabel Collados-Maestre2, Luis Marco-Gómez2, Fernando A Lopez-Prats3.   

Abstract

BACKGROUND: The purpose of this study was to compare outcomes and complications after total knee arthroplasty (TKA) between end-stage renal disease (ESRD) patients and patients without renal insufficiency.
METHODS: A retrospective case-control study with prospectively collected data was carried out to compare 15 ESRD patients with a matched cohort of 30 nonrenal patients. Clinical evaluation was performed by the Knee Society Scores (KSS) and reduced Western Ontario MacMasters University (WOMAC) questionnaire. Radiologic evaluation was also performed.
RESULTS: The mean postoperative follow-up was 3.4 years (range, 2-6). In the ESRD, the mean hospital stay and transfusion rate were significantly higher than control group. Preoperatively and postoperatively, there were no significant differences in KSS-knee or WOMAC-pain scores, but KSS-function and WOMAC-function were significantly lower in the ESRD group. There was no significant difference between groups in mean gain of KSS-function (45.1 vs 43.2, P = .071), but there was a significant lower mean gain for WOMAC-function in the ESRD group (37.0 vs 44.0, P = .003). In the ESRD group, 3 patients presented medical complications which were treated successfully. There were 2 superficial infections and no deep infection. One patient died at 30 postoperative months. In the control group, there were no medical complications, infections, or deaths during the follow-up period. In ESRD group, there were 2 knees with radiolucent lines. In either group, there was no loosening or revision.
CONCLUSION: TKA was a successful procedure for knee osteoarthritis in most ESRD patients. Dialysis patients may expect improvement in function after TKA, but the patients need to be informed of the possible risk of postoperative severe medical complications due to nature of their renal disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic renal disease; dialysis patient; end-stage renal disease; hemodialysis; total knee arthroplasty

Mesh:

Year:  2016        PMID: 27129761     DOI: 10.1016/j.arth.2016.03.049

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  5 in total

1.  Risk Factors for Blood Transfusions in Primary Anatomic and Reverse Total Shoulder Arthroplasty for Osteoarthritis.

Authors:  Danny Lee; Ryan Lee; Safa C Fassihi; Monica Stadecker; Jessica H Heyer; Seth Stake; Kyla Rakoczy; Thomas Rodenhouse; Rajeev Pandarinath
Journal:  Iowa Orthop J       Date:  2022-06

2.  Postoperative mortality in patients on chronic dialysis following elective surgery: A systematic review and meta-analysis.

Authors:  Dharmenaan Palamuthusingam; Arun Nadarajah; Elaine M Pascoe; Jonathan Craig; David W Johnson; Carmel M Hawley; Magid Fahim
Journal:  PLoS One       Date:  2020-06-26       Impact factor: 3.240

3.  Morbidity after elective surgery in patients on chronic dialysis: a systematic review and meta-analysis.

Authors:  Dharmenaan Palamuthusingam; Arun Nadarajah; David Wayne Johnson; Elaine Marie Pascoe; Carmel Marie Hawley; Magid Fahim
Journal:  BMC Nephrol       Date:  2021-03-18       Impact factor: 2.388

4.  Effect of preoperative long-term opioid therapy on patient outcomes after total knee arthroplasty: an analysis of multicentre population-based administrative data.

Authors:  C Michael Goplen; Sung Hyun Kang; Jason R Randell; C Allyson Jones; Donald C Voaklander; Thomas A Churchill; Lauren A Beaupre
Journal:  Can J Surg       Date:  2021-03-05       Impact factor: 2.089

Review 5.  Effect of chronic kidney disease on total knee arthroplasty outcomes: a meta-analysis of matched control studies.

Authors:  Chongjie Cheng; Yan Yan; Qidong Zhang; Wanshou Guo
Journal:  Arthroplasty       Date:  2021-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.